Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia

Objective: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism's self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some au...

Full description

Bibliographic Details
Main Authors: Ahmet Menteşe, Nergiz Erkut, Selim Demir, Serap Özer Yaman, Aysegül Sümer, Seniz Doğramacı, Ahmet Alver, Mehmet Sönmez
Format: Article
Language:English
Published: Galenos Publishing House 2017-11-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-44442
_version_ 1797909156327325696
author Ahmet Menteşe
Nergiz Erkut
Selim Demir
Serap Özer Yaman
Aysegül Sümer
Seniz Doğramacı
Ahmet Alver
Mehmet Sönmez
author_facet Ahmet Menteşe
Nergiz Erkut
Selim Demir
Serap Özer Yaman
Aysegül Sümer
Seniz Doğramacı
Ahmet Alver
Mehmet Sönmez
author_sort Ahmet Menteşe
collection DOAJ
description Objective: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism's self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some autoimmune diseases and carcinomas, but the mechanisms underlying this immune response have not yet been explained. The aim of this study was to evaluate CA I and II autoantibodies in patients with acute myeloid leukemia (AML) and to provide a novel perspective regarding the autoimmune basis of the disease. Materials and Methods: Anti-CA I and II antibody levels were investigated using ELISA in serum samples from 30 patients with AML and 30 healthy peers. Results: Anti-CA I and II antibody titers in the AML group were significantly higher compared with the control group (p=0.0001 and 0.018, respectively). A strong positive correlation was also determined between titers of anti-CA I and II antibodies (r=0.613, p=0.0001). Conclusion: Our results suggest that these autoantibodies may be involved in the pathogenesis of AML. More extensive studies are now needed to reveal the entire mechanism.
first_indexed 2024-04-10T11:03:58Z
format Article
id doaj.art-049d75eab83a4a9199cdff184ca7e073
institution Directory Open Access Journal
issn 1308-5263
language English
last_indexed 2024-04-10T11:03:58Z
publishDate 2017-11-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-049d75eab83a4a9199cdff184ca7e0732023-02-15T16:19:31ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632017-11-0134430731310.4274/tjh.2016.0341TJH-44442Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid LeukemiaAhmet Menteşe0Nergiz Erkut1Selim Demir2Serap Özer Yaman3Aysegül Sümer4Seniz Doğramacı5Ahmet Alver6Mehmet Sönmez7Karadeniz Technical University Vocational School of Health Sciences, Program of Medical Laboratory Techniques, Trabzon, TurkeyKaradeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, TurkeyKaradeniz Technical University Faculty of Health Sciences, Department of Nutrition and Dietetics, Trabzon, TurkeyKaradeniz Technical University Faculty of Medicine, Department of Medical Biochemistry, Trabzon, TurkeyRecep Tayyip Erdoğan University Faculty of Health Services, Department of Nursing, Rize, TurkeyKaradeniz Technical University Faculty of Medicine, Department of Medical Biochemistry, Trabzon, TurkeyKaradeniz Technical University Faculty of Medicine, Department of Medical Biochemistry, Trabzon, Turkey; Recep Tayyip Erdoğan University Faculty of Medicine, Department of Medical Biochemistry, Rize, TurkeyKaradeniz Technical University Faculty of Medicine, Department of Hematology, Trabzon, TurkeyObjective: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism's self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some autoimmune diseases and carcinomas, but the mechanisms underlying this immune response have not yet been explained. The aim of this study was to evaluate CA I and II autoantibodies in patients with acute myeloid leukemia (AML) and to provide a novel perspective regarding the autoimmune basis of the disease. Materials and Methods: Anti-CA I and II antibody levels were investigated using ELISA in serum samples from 30 patients with AML and 30 healthy peers. Results: Anti-CA I and II antibody titers in the AML group were significantly higher compared with the control group (p=0.0001 and 0.018, respectively). A strong positive correlation was also determined between titers of anti-CA I and II antibodies (r=0.613, p=0.0001). Conclusion: Our results suggest that these autoantibodies may be involved in the pathogenesis of AML. More extensive studies are now needed to reveal the entire mechanism.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-44442acute myeloid leukemiaautoantibodycancercarbonic anhydrase
spellingShingle Ahmet Menteşe
Nergiz Erkut
Selim Demir
Serap Özer Yaman
Aysegül Sümer
Seniz Doğramacı
Ahmet Alver
Mehmet Sönmez
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
Turkish Journal of Hematology
acute myeloid leukemia
autoantibody
cancer
carbonic anhydrase
title Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
title_full Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
title_fullStr Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
title_full_unstemmed Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
title_short Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
title_sort autoantibodies against carbonic anhydrase i and ii in patients with acute myeloid leukemia
topic acute myeloid leukemia
autoantibody
cancer
carbonic anhydrase
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-44442
work_keys_str_mv AT ahmetmentese autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT nergizerkut autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT selimdemir autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT serapozeryaman autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT aysegulsumer autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT senizdogramacı autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT ahmetalver autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia
AT mehmetsonmez autoantibodiesagainstcarbonicanhydraseiandiiinpatientswithacutemyeloidleukemia